| Article | Added |
|---|
| Good for Some, Good for All | 05-24-12 |
| Nokia Joins X Prize in $2.25M Wireless Health 'sensing Challenge? | 05-24-12 |
| SD Life Sciences Roundup: Takeda Consolidates, Startups Raise Cash | 05-24-12 |
| The 2012 New York ASCO Checklist | 05-24-12 |
| EMC, Ember, Spindle, Yottaa, & More Boston-Area Deals | 05-24-12 |
| Halo Gathers $1.1M From Patient Groups for Muscular Dystrophy Drug | 05-24-12 |
| MediciNova Misses Primary Goal in Mid-Stage Trial of IV Asthma Drug | 05-23-12 |
| What's New With Loveland Technologies, Axonia, 3D Biomatrix? | 05-23-12 |
| Analytic Software Wins Janssen Prize to Reduce Hospital Readmissions | 05-23-12 |
| Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug | 05-23-12 |
| Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 | 05-23-12 |
| San Diego BizTech Roundup: Qualcomm, Helix Wind, and 'skqueak? | 05-22-12 |
| San Diego's Free EvoNexus Tech Incubator Gains Qualcomm Expertise | 05-22-12 |
| Undaunted by Wall Street ?Penalty Box,? Keryx Focuses on Kidney Drug | 05-22-12 |
| Wireless Health Summit Showcases Incentive Prizes as Tool for Change | 05-22-12 |
| Who's on Biotech's Endangered Species List? Mid-Sized Drugmakers | 05-21-12 |
| Sue Siegel Leaves MDV to Run $6B GE Health Unit | 05-21-12 |
| iPierian Zeroes In on Antibodies for Alzheimer's, Neurodegeneration | 05-21-12 |
| Who's on Biotech's Endangered Species List? Mid-Sized Drug Developers | 05-21-12 |
| For Those on Watch, Hope Springs Eternal as Hair Trials Inch Along | 05-18-12 |
| CardioKinetix Clears 2-Year Study with Implant for Heart Failure | 05-18-12 |
| Promedior, Aveo, Ra, and More Boston Life Sciences Headlines | 05-18-12 |
| SD Biotech Roundup: Elevation Pharmaceuticals, BioSurplus, and More | 05-17-12 |
| Xconomist of the Week: Tom Maniatis on Prize4Life and ALS Research | 05-17-12 |
| Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study | 05-16-12 |
| Dendreon's Provenge Works Best for Patients With Low PSA, Scientists Say | 05-16-12 |
| VC Guru Mendelson on MI's Entrepreneurial Ecosystem (And Why There's Hope) | 05-16-12 |
| Hutch, UW Scientists Find Elusive Cancers With Adaptive Diagnostic | 05-16-12 |
| Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies | 05-16-12 |
| Theraclone Passes First Clinical Test with Flu-Fighting Antibody | 05-15-12 |
| Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO | 05-15-12 |
| Coaching Program Springboard Hits Boston With Life Sciences Entrepreneurs | 05-15-12 |
| Five Questions for E&Y's David DeMarco on the Future of Health IT | 05-15-12 |
| JumpStart, NEI Plan New High Tech Accelerator in Detroit | 05-14-12 |
| ASCO Preview: Eight Cancer Drugs to Watch at the Big Show | 05-14-12 |
| Boston Life Sciences News From Vertex, Eleven, RXi, & More | 05-11-12 |
| Verdezyne Raises $10.6M to Advance Sustainable Chemicals Technology | 05-11-12 |
| SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More | 05-10-12 |
| IDRI, Aeras Team Up to Develop Tuberculosis Vaccine | 05-09-12 |
| NY's Cancer Research Institute Looks to Boost Cancer Immunotherapy | 05-09-12 |
| A 10-Point Plan to Stimulate Biotech & the Economy as a Whole | 05-09-12 |
| Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future | 05-08-12 |
| San Diego's MediciNova Nears Turning Point with Lead Drug for Asthma | 05-08-12 |
| San Diego's Celladon Extends Round to $53M, Opens European Office | 05-08-12 |
| Sutro Biopharma Pulls in $16M for New Antibody Drugs | 05-08-12 |
| Eleven Biotherapeutics Raises $20M to Advance Dry-Eye Drug | 05-08-12 |
| First Comes The $1,000 genome, Then Comes The $10,000 Analysis | 05-08-12 |
| Dendreon Meets Expectations with $82M in 1st Quarter Provenge Sales | 05-07-12 |
| Antibiotic R&D is in Trouble: Here's One Way to Fix It | 05-07-12 |
| SD BizTech Roundup: Ortiva Acquired, EcoATM, & Grid2Home Raise Cash | 05-07-12 |
| Antibiotic R&D is in Trouble: Here's a Fix | 05-07-12 |
| Retrophin, Headed by Controversial Hedge Fund Chief, Raises $4M | 05-07-12 |
| Vertex Shares Boom on Cystic Fibrosis Results | 05-07-12 |
| Vertex Shows Effect With Two-Drug Combo for Cystic Fibrosis, Shares Boom | 05-07-12 |
| Vertex Shows Signs of Effect With Two-Drug Combo for Cystic Fibrosis | 05-07-12 |
| Free Markets Are Failing Antibiotics: Here's A Way to Fix Things | 05-07-12 |
| Winners of ?MI 50 Companies to Watch? Awards To Be Announced | 05-03-12 |
| Analyst: Dendreon's Growth Stalling With Cancer Docs as Rival Gains | 05-04-12 |
| NIH's Collins Lauds ?Unprecedented? Partnership at NY Bio Confab | 05-04-12 |
| Nirvanix Raises $25M to Fuel Expansion of Cloud Storage Services | 05-04-12 |
| SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy | 05-03-12 |
| Winners of ?MI 50 Companies to Watch? Awards To Be Announced Tonight | 05-03-12 |
| Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? | 05-03-12 |
| Buying SD's Ortiva Wireless Adds Video Optimization to Allot's Tools | 05-03-12 |
| Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work | 05-02-12 |
| After 6 Years and $26M, Insolvent Chumby Selling Remaining Assets | 05-02-12 |
| Boston Deals: Hologic, CustomMade, and the MIT Clean Energy Prize | 05-02-12 |
| Pfizer Takes on Genzyme With New Gaucher Drug | 05-02-12 |
| The Affymetrix Alumni: Where Are They Now? | 05-02-12 |
| 5 Things to Do Before the New Patent Law Takes Full Effect | 05-02-12 |
| San Diego's EcoATM Raises $17M As It Builds Recycling Cash Machine | 05-01-12 |
| Innovation Report Shows San Diego Added 695 Tech Jobs at End of 2011 | 05-01-12 |
| Mersana Adds $4M For Next-Generation ?Armed? Cancer Drugs | 05-01-12 |
| San Diego BizTech Roundup: Independa, Zui.com, Bandsintown, and More | 04-30-12 |
| Berwick's Advice: Cost-Effectiveness Is Here to Stay | 04-30-12 |
| Hologic Buys Gen-Probe for $3.7B, Making Molecular Diagnostics Push | 04-30-12 |
| New Health IT Initiative Takes Cognitive Medical Beyond Military | 04-30-12 |
| Biotech IPOs Start to Show Some Modest Signs of Life | 04-30-12 |
| Michigan State Creates Spartan Innovations to Launch Spin-Offs | 04-27-12 |
| Taking Open Biology to the Next Level: Notes from the Sage Congress | 04-27-12 |
| SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More | 04-27-12 |
| Genzyme, Epizyme, & Rib-X Among the Week's Life Sciences Newsmakers | 04-27-12 |
| UW Startups Look to Improve Bras, Bicycle Ads, Mental Health | 04-26-12 |
| Announcing Xconomy's Napa Summit: Keeping America Growing | 04-26-12 |
| Big Data, Big Biology, and the ?Tipping Point? in Quantified Health | 04-26-12 |
| Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections | 04-26-12 |
| Epizyme Gets $90M in Epigenetics Partnership with Celgene | 04-26-12 |
| Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig's Disease | 04-25-12 |
| Illumina Opens Apple-Inspired App Store for DNA Software Developers | 04-25-12 |
| MI Pre-Seed Capital Fund Awards $444,000 in Microloans to 12 Tech Startups | 04-25-12 |
| N-Gene Digs Up Funds to Boost ?Heat Shock? Drug in Diabetes and MD | 04-25-12 |
| General Assembly Founder Hargreaves, Atlas? Destin Join XSITE Lineup | 04-25-12 |
| IMS Health Buys DecisionView For Programs to Speed Clinical Trials | 04-24-12 |
| New Data on Genzyme MS Drug Shows Improvement in Disability | 04-24-12 |
| The JOBS Act?The ?IPO On-Ramp? Makes IPOs Easier | 04-24-12 |
| George Rathmann, Founding CEO of Amgen and Icos, Dies at 84 | 04-24-12 |
| AstraZeneca Reloads its Pipeline with Ardea Deal, Could be Still Hunting | 04-23-12 |
| Sapphire Energy CEO Jason Pyle's Parting Thoughts on Big Biofuel | 04-23-12 |
| Amazon's Fight Against Content Middlemen: Books, TV, Movies, Games | 04-23-12 |
| What Are the Hottest Targets in Biotech Today? | 04-23-12 |
| San Diego's Q1 Venture Activity Surges on One Mega Deal | 04-20-12 |
| Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers | 04-20-12 |
| CEO Changes in Planned Succession at San Diego's Sapphire Energy | 04-20-12 |
| SD Life Sciences Roundup: Accelrys, Illumina, & RainTree Oncology | 04-19-12 |
| Cell Therapeutics Shells Out $30M for New Drug | 04-19-12 |
| Progress for Pervasis and InVivo: A Boost for Regenerative Efforts? | 04-19-12 |
| Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs | 04-19-12 |
| Illumina Stays Independent, Roche Walking Away | 04-18-12 |
| Sage Bionetworks Moves from Thinking Stage to Doing Stage | 04-18-12 |
| Small is Beautiful in Q1 Venture Deals as VCs Write Lots of Checks | 04-18-12 |
| Five Questions: Acorda CEO Ron Cohen on the Future of Neurology R&D | 04-17-12 |
| Enzyme Maker Alcresta Nabs $10M from Third Rock, Bessemer, Frazier | 04-17-12 |
| Dendreon CEO John Johnson: ?This is My Last Stop? | 04-17-12 |
| Abbott's Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 | 04-16-12 |
| Pervasis, Flagship, SeventhSense, & More Boston Life Sciences Newsmakers | 04-13-12 |
| Pervasis, Flagship, SeventhSense, & More Boston Life Sciences Newsmakers | 04-13-12 |
| Tioga Investor Thomas McNerney Keeping Busy After San Diego Move | 04-12-12 |
| Provid Pharma Leans on MS Society's Venture Fund to Boost Lead Drug | 04-12-12 |
| SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals | 04-12-12 |
| Cardinal Health Hires West Wireless Health Institute's Inaugural CEO | 04-11-12 |
| BioPharma Needs A Safe, Reliable Way To Repair Broken Genes | 04-11-12 |
| Cardinal Hires West Wireless Health Institute's Inaugural CEO | 04-11-12 |
| Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer | 04-11-12 |
| AisleBuyer, Crashlytics, Cymfony, & More Boston Dealmakers | 04-11-12 |
| UCSD Spinoff NexDx Aims to Diagnose Rheumatoid Arthritis | 04-11-12 |
| In San Diego Restart, Verenium Erases Debt, Looks to Expand Products | 04-10-12 |
| Investing in Biotech Isn?t Just for Investors Anymore | 04-09-12 |
| Merck Teams With Flagship to Bankroll Early Biotech Ventures | 04-10-12 |
| Merck Teams With Flagship to Bankroll Early Biotech Ventures | 04-10-12 |
| J&J Group Awards 3 Finalists $50,000 Each for Gaps in Patient Care | 04-10-12 |
| Oncothyreon Marches On With 'son of Stimuvax? Cancer Vaccine | 04-10-12 |
| Optimer Discloses Shakeup Prompted by Chairman's Deal in Taiwan | 04-09-12 |
| Investing in Biotech Isn?t Just for Investors Anymore | 04-09-12 |
| New England's Emerging Biotech Stars: An Xconomy Forum In Pictures | 04-09-12 |
| Presage Looks to Help Millennium Pick Cancer Drug Winners Early | 04-06-12 |
| AVI Biopharma Mulls Deal After Mixed Data With Muscular Dystrophy Drug | 04-06-12 |
| Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News | 04-06-12 |
| SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals | 04-05-12 |
| TechTown Report Sheds Light on Its Economic Impact | 04-05-12 |
| Reinventing Biotech's Business Model: The Photo Gallery | 04-04-12 |
| Reinventing Biotech's Business Model: The Photo Gallery | 04-04-12 |
| SD Tech Roundup: ServiceNow Files IPO, On-Ramp Wireless, SwoopThat | 04-04-12 |
| See You Today at New England's Emerging Biotech Stars***SOLD OUT*** | 04-04-12 |
| See You Today at New England's Emerging Biotech Stars: Just 8 Tickets Left | 04-04-12 |
| OvaScience Adds $37M for Fertility Treatments | 04-04-12 |
| Boston Deals: Funding for FRX, Allocure, Good Start, & FirstBest | 04-03-12 |
| See You This Afternoon at ?Reinventing Biotech's Business Model? | 04-03-12 |
| Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup | 04-03-12 |
| AVI Biopharma Passes Small Study in Muscular Dystrophy | 04-02-12 |
| San Diego's Sapphire Energy Raises $144M for ?Green Crude Farm? | 04-02-12 |
| Xconomy Boston's Top 20 Stories of Q1: Editor's Picks | 04-02-12 |
| Biotech Can?t Sidestep Cost-Effectiveness Anymore | 04-02-12 |
| Genentech, ImmunoGen 'smart Bomb? for Breast Cancer Clears Big Hurdle | 03-30-12 |
| Genoa Pharma Aims To Satisfy Big Pharma's Hunger for IPF Drugs | 03-30-12 |
| Late Add: John Mendlein Joins ?Reinventing Biotech? Lineup April 3 | 03-29-12 |
| Wayne State Launches Pre-Seed Fund For Student Tech Startups | 03-29-12 |
| Roche Raises Illumina Takeover Bid to $51/Share | 03-29-12 |
| Oncothyreon Grabs $47M in Stock Offering | 03-29-12 |
| LiquidGrids Re-Launches Social Media Analytics for Health Industry | 03-29-12 |
| MAP Pharmaceuticals Gets Rare Benefit of the Doubt With Migraine Drug | 03-29-12 |
| Third Rock's Mark Levin: ?Ultra-Super Positive? on Biotech Innovation | 03-29-12 |
| Accelerator Gets New Chief Scientist, David McElligott | 03-28-12 |
| Amylin Booms on Report it Rejected Bristol's $3.5B Takeover Bid | 03-28-12 |
| On-Ramp Wireless, Learning From the Past, Says Its System Is Ready | 03-28-12 |
| Boston's Deal News: Tracelytics, Tesaro, & A New Innovation Center | 03-28-12 |
| Theraclone's Cliff Stocks Joins ?Reinventing Biotech? Lineup Apr. 3 | 03-27-12 |
| Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen | 03-27-12 |
| DecisionView Looks to Help Speed Up Pharma's Painfully Slow Trials | 03-27-12 |
| PATH Names Former Tech Exec Steve Davis as New CEO | 03-26-12 |
| San Diego Tech Roundup: Flud, Verve, and a 'swiss Cheese? Job Market | 03-26-12 |
| Aveo's Ha-Ngoc to Interview Third Rock's Mark Levin at April 4 Forum | 03-26-12 |
| Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks | 03-26-12 |
| Glaxo and J&J's Shrewd Move Will Help the Biotech Ecosystem | 03-23-12 |
| UCSD Proposes Innovator Space as Entrepreneurial Life Sciences Hub | 03-23-12 |
| Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug | 03-23-12 |
| The Supreme Court's Bad Precedent for Innovation | 03-22-12 |
| ?Breakthrough? in Quantified Health Sets Stage for Innovation Summit | 03-22-12 |
| Grant Funding Helps Karyopharm Speed Lead Cancer Drug to Clinic | 03-22-12 |
| 12 Investing and Business Gems from Avalon's Kevin Kinsella | 03-22-12 |
| Paul Allen's Big Bet to ?Uncover the Essence of What Makes Us Human? | 03-22-12 |
| Paul Allen Commits $300M to Expand Institute for Brain Science | 03-21-12 |
| Verve Raises $7M, Studies Mobile ?Paradox? for Old Media Customers | 03-21-12 |
| OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics | 03-21-12 |
| Boston's Deal News: Amazon Acquires Kiva, and Tech IPOs | 03-21-12 |
| Ariad and Merck Face Tough FDA Review of Sarcoma Pill | 03-20-12 |
| Biotech's New Frontier: Europe? | 03-19-12 |
| Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases | 03-19-12 |
| Biotech Lagging Behind Go-Go Web Valuations, Survey Says | 03-20-12 |
| Venture MI II Invests $15M in Wisconsin Early-Stage Fund | 03-19-12 |
| San Diego Tech Roundup: Givit, ID Analytics, and Rain on the Parade | 03-19-12 |
| Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases | 03-19-12 |
| Biotech's New Frontier: Europe? | 03-19-12 |
| In Boston Life Sciences News: Akili, Kala, And Genocea | 03-16-12 |
| OncoGenex Snags $50M for Prostate Cancer Drug Plan | 03-16-12 |
| Peter Schultz on New Merck-Funded Institute: ?We?re Getting Lots of Resumes? | 03-16-12 |
| Life Sciences News Roundup: InflammaGen, HemaQuest, ImThera & More | 03-16-12 |
| Peter Schultz on New Merck-Funded Institute: ?We?re Getting Lots of Resumes? | 03-16-12 |
| Groove Biopharma Joins Stellar Lineup at ?Reinventing Biotech? Apr. 3 | 03-16-12 |
| The Greater Seattle Brain Science Cluster | 03-16-12 |
| In Boston Life Sciences News: Akili, Kala, And Genocea | 03-16-12 |
| Lee Hood's P4 Initiative Finds Community Partner, PeaceHealth | 03-15-12 |
| Shire Shells Out $100M to Buy Ferrokin Biosciences | 03-15-12 |
| Lee Hood's P4 Medicine Institute Gets New Partner, PeaceHealth | 03-15-12 |
| Merck Returns to SD, Pouring $90M Into New Schultz-Led Institute | 03-15-12 |
| Genocea CEO Chip Clark to Speak at Xconomy's April 4 Biotech Forum | 03-15-12 |
| Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb | 03-13-12 |
| In Search of Capital, San Diego Taking Startups on Roadshows to VCs | 03-14-12 |
| Seattle Children's Sets Up Rare Biobank to Study Premature Birth | 03-14-12 |
| Akili Interactive Seeks to Make Video Games That Heal, Not Harm | 03-14-12 |
| Seattle Children's Sets Up Rare Pregnancy Biobank | 03-14-12 |
| San Diego BizTech Roundup: RealAge, Qualcomm, Angel Deals, & More | 03-13-12 |
| Seattle Genetics Digs Deeper Into the Proverbial Haystack | 03-13-12 |
| Apperian, Exinda, Adelphic, & More Boston-Area Dealmakers | 03-13-12 |
| Seattle Genetics Digs Into the Haystack, Looking for More than One Needle | 03-13-12 |
| Seattle Genetics Found Its Needle in the Haystack, Sparking Big Push For More | 03-13-12 |
| Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb | 03-13-12 |
| Seattle Genetics Digs into the Haystack, Looking for More Needles | 03-13-12 |
| Women in Bio, After Gaining Momentum Elsewhere, Arrives in SF | 03-13-12 |
| A Seussian Guide to BioPharma | 03-13-12 |
| HemaQuest Gets $13M Transfusion in Extension of Series B Financing | 03-12-12 |
| AIDS Drugs Were the Start. Let's See More FDA Accelerated Approvals | 03-12-12 |
| San Diego's InflammaGen Advances Therapy to Mitigate Effects of Shock | 03-12-12 |
| Aastrom Closes $40 Million Financing Deal with Eastern Capital | 03-09-12 |
| J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation | 03-08-12 |
| OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up | 03-08-12 |
| Microsoft's Mayhem: Remote Controls for Everything (Eventually) | 03-09-12 |
| OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up | 03-08-12 |
| 4s3, With $20M in Tow, Pursues Route for Delivering Drugs to Muscle | 03-08-12 |
| SavingStar, Exinda, & NeuroPhage: A Trio of Boston Startup Deals | 03-08-12 |
| New England's Emerging Biotech Stars: The Agenda | 03-08-12 |
| J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation | 03-08-12 |
| San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More | 03-08-12 |
| The Thinking Behind Domain's $760M Life Sciences Deal in Russia | 03-07-12 |
| Reinventing Biotech on April 3: Here's the Agenda | 03-08-12 |
| 4s3, With $20M in Tow, Pursues Route for Delivering Drugs to Muscle | 03-08-12 |
| The Thinking Behind Domain's $760M Life Sciences Deal in Russia | 03-07-12 |
| Molecular Health Sets up in NYC With Personalized Med Tools | 03-07-12 |
| How Biogen Idec Overhauled R&D Under Doug Williams | 03-07-12 |
| BG Medicine, Bottomline, 4s3 Bioscience Among the Week's Dealmakers | 03-07-12 |
| Qualcomm's Irwin Jacobs Becomes CEO Emeritus, 20 Years After IPO | 03-06-12 |
| Disease Foundations Play Growing Role in Biotech Business Model | 03-06-12 |
| Oncothyreon Shares Tumble on Lung Cancer Study Speculation | 03-06-12 |
| San Diego's Aragon Raises $42 Million, Targets Hormone-Driven Cancers | 03-06-12 |
| Connect Bestows ?Hall of Fame? Award on Hybritech Founder Ted Greene | 03-05-12 |
| Five Reasons Illumina Should Fight Roche's Insulting Low-Ball Bid | 03-05-12 |
| Connect and Xconomy Present: The Rock Stars of Innovation 1 Stop Tour | 03-02-12 |
| CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs | 03-02-12 |
| Concert, Alere, TremRx, & More Names from Boston Life Sciences News | 03-02-12 |
| SD Life Sciences (and Cleantech) Roundup: DexCom, Ligand, Genomatica | 03-01-12 |
| U-M Business Competition Awards $90K to Student Startups | 03-01-12 |
| Concert Nabs $200M Deal From Avanir to Make Psych Drugs | 02-29-12 |
| Xconomist of the Week: Roger Perlmutter's Parting Thoughts on Amgen | 03-01-12 |
| With $21.7M in New Funding, Luxtera Signs Deal to Make Optical Chip | 03-01-12 |
| Harvard-Born TremRx Pursues New Vaccine Technology | 02-29-12 |
| Sapphire Boosts Yields from Blue-Green Algae, Signs Earthrise Deal | 02-29-12 |
| Concert Nabs $200M Deal From Avanir to Make Psych Drugs | 02-29-12 |
| Verinata's Big Day Arrives, With Prenatal Down Syndrome Test Debut | 02-29-12 |
| Charles River, FirstFuel, Quiet Logistics, & More Boston Deal News | 02-29-12 |
| Dendreon Adds ImClone Vets to New Management Team | 02-28-12 |
| MBI Helps Biotech Companies De-Risk and Expand | 02-28-12 |
| Dendreon Stock Tumbles As Company Projects ?Moderate? Sales Growth | 02-27-12 |
| Satori Cultivates Prolific Herb for Promising Alzheimer's Weapon | 02-28-12 |
| Dendreon Stock Tumbles As Company Projects ?Moderate? Sales Growth | 02-27-12 |
| Seven MI Universities to Partner in Tech Transfer Talent Network | 02-27-12 |
| San Diego Tech Roundup: Entropic, Xpenser, OneRoof Energy, & More | 02-27-12 |
| Bruce Booth, a LifeSciVC Shining Some Much-Needed Light on Biotech | 02-27-12 |
| Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris | 02-23-12 |
| Crescendo Bioscience Takes Arthritis Into the World of Hard Data | 02-24-12 |
| Enanta, Satori, Vertex & More of the Week's Life Sciences Newsmakers | 02-24-12 |
| San Diego Life Sciences Roundup: Receptos, Vital Therapies, & More | 02-23-12 |
| Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study | 02-23-12 |
| Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris | 02-23-12 |
| Transparency Launches as Linux of Drug Development | 02-23-12 |
| Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3 | 02-23-12 |
| Satori Snaps Up $15M for Alzheimer's Drugs | 02-23-12 |
| SE Michigan Startups Nab Pre-Seed, Microloan Funding | 02-22-12 |
| InDi, Lee Hood's Vision for Spotting Cancer in Blood, Snags $10M | 02-22-12 |
| UW's Matsuoka Stays at Nest, Brain Research Center Gets New Director | 02-22-12 |
| GreatPoint, Enanta, NextView, & More Boston Dealmakers | 02-22-12 |
| Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis | 02-21-12 |
| Join The Group! | 02-21-12 |
| Oh, And One More Thing: A Wowser Moment in DNA Sequencing | 02-21-12 |
| Cell Therapeutics Stock Rises on EU Recommendation for Lymphoma Drug | 02-17-12 |
| MicroCHIPS Shows Promise of Bone Drug Implant in First Human Trial | 02-16-12 |
| Signs of Resurgence in SD as EvoNexus Opens Tech Incubator | 02-17-12 |
| Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News | 02-17-12 |
| Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News | 02-17-12 |
| Open Source May be the Answer for Pharma and Biotech | 02-17-12 |
| Mnemosyne, Hydra, On-Q-ity, and More New England Life Sciences News | 02-17-12 |
| SD Life Sciences Roundup: Celladon, Gen-Probe, Organovo, and More | 02-16-12 |
| MicroCHIPS Shows Promise of Bone Drug Implant in First Human Trial | 02-16-12 |
| On-Q-ity Raises $5M, Names GSK Vet as CEO | 02-15-12 |
| Amp Orthopedics Takes Aim at Boomers? Achy Knees and Shoulders | 02-16-12 |
| Will New Business Models Enhance or Endanger Drug Discovery? | 02-16-12 |
| Celladon Raises $43M, Wins Fast-Track Status for Heart Treatment | 02-16-12 |
| EPA Expands Innovative Compound-Testing Collaboration With BioSeek | 02-15-12 |
| EPA Expands Innovative Compound-Testing Collaboration With BioSeek | 02-15-12 |
| On-Q-ity Raises $5M, Names GSK Vet as CEO | 02-15-12 |
| AirHop and InterDigital Working to Combine ?Network of Networks? | 02-15-12 |
| Energy Points, Biogen, Navinet, & More Boston Dealmakers | 02-15-12 |
| On-Q-ity Raises $5M, Names GSK Vet as CEO | 02-15-12 |
| FDA Approves New Gen-Probe Test for Men at Risk of Prostate Cancer | 02-15-12 |
| Hydra Makes Progress in Pain With First Trial and New Partnership | 02-15-12 |
| Energy Points, Biogen, Navinet, & More Boston Dealmakers | 02-15-12 |
| Biogen Idec Lets Stromedix Do The Hard Part | 02-14-12 |
| Biogen Buys Stromedix for $75M, Regaining Fibrosis Drug | 02-14-12 |
| Intellect Embraces Wide-Ranging Approach to Fighting Brain Diseases | 02-14-12 |
| Organovo Raises $6.5M, Lists on OTC, in Alternative Public Offering | 02-14-12 |
| RetroSense Therapeutics? Blindness Therapy Lands Investment | 02-13-12 |
| Option to Buy: The New Face of Biotech Funding? | 02-13-12 |
| Option to Buy: The New Face of Biotech Funding? | 02-13-12 |
| Synchroneuron, Radius, Acetylon, & More Boston Life Sciences News | 02-10-12 |
| SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen | 02-10-12 |
| Persistence Pays Off for Synchroneuron Founder | 02-09-12 |
| Persistence Pays Off for Synchroneuron Founder With $6M Series A | 02-09-12 |
| Celgene Pours $15M Into Acetylon, Takes ?Observer? Role on Board | 02-09-12 |
| Celgene Pours $15M Into Acetylon, Takes ?Observer? Role on Board | 02-09-12 |
| Celgene Pours $15M Into Acetylon, Takes ?Observer? Role on Board | 02-09-12 |
| NYC Consortium Promotes Collaboration Among Scientific Researchers | 02-08-12 |
| OncoSec Medical Advancing Inovio's Technology Against Cancer | 02-08-12 |
| Gates, 13 Pharmas Join $785M Push for Neglected Diseases | 01-30-12 |
| Brightcove, Radius, Synchroneuron, & More Boston-Area Dealmakers | 02-08-12 |
| Life Sciences VC Investing Up in Dollar Value, Down in Deal Volume | 02-07-12 |
| Radius Health Seeks $86M IPO | 02-07-12 |
| Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M | 02-07-12 |
| Radius Health Seeks $86M IPO | 02-07-12 |
| Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M | 02-07-12 |
| San Diego Tech Roundup: Web Startups Heat Up, New Incubator Opens | 02-06-12 |
| FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects | 02-06-12 |
| FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects | 02-06-12 |
| Never Back Smug: A Lesson for Life Sciences From Newt Gingrich | 01-30-12 |
| Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug | 01-31-12 |
| Flagship Ventures Plans to Open Michigan Office | 02-01-12 |
| Calling All Boston-Area Marketing Mavens? | 02-03-12 |
| San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy | 02-03-12 |
| FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News | 02-03-12 |
| Wayne State Hires Former Pharma Exec to Lead Tech Commercialization Efforts | 02-02-12 |
| San Diego Life Sciences Strengthened in Recession, Outpacing Nation | 02-01-12 |
| Flagship Ventures Plans to Open Michigan Office | 02-01-12 |
| Dendreon Names John Johnson CEO After Volatile Year | 02-01-12 |
| Vertex's Big Day Felt Like Moon Landing, Seattle Researcher Says | 02-01-12 |
| AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics | 02-01-12 |
| Avila, iRobot, Verastem, Illume, & More Boston Deal News | 02-01-12 |
| Cell Therapeutics Pulls FDA Application, Saying It Isn?t Ready For Panel | 01-30-12 |
| FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis | 01-30-12 |
| Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug | 01-31-12 |
| FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis | 01-30-12 |
| Optimer, Following Pfizer's Playbook, Has Big Plans for Antibiotic | 01-31-12 |
| Four Themes to Watch in Personalized Medicine | 01-30-12 |
| Gates, 13 Pharmas Join $785B Push for Neglected Diseases | 01-30-12 |
| San Diego Tech Roundup: Qualcomm, TechStars, Apps Challenge & More | 01-30-12 |
| FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis | 01-30-12 |
| Vision Without Execution is Hallucination | 01-30-12 |
| Cell Therapeutics Pulls FDA Application, Saying It Isn?t Ready For Panel | 01-30-12 |
| Never Back Smug: A Lesson for Life Sciences From Newt Gingrich | 01-30-12 |
| ConforMIS Adds $89M to Expand Sales, Manufacturing, Technology | 01-30-12 |
| Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug | 01-27-12 |
| Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall | 01-27-12 |
| 2012 Venture Outlook: Some Bright Spots and Some Gloom | 01-27-12 |
| OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation | 01-27-12 |
| Why Biogen Idec Got Out of the Corporate VC Business | 01-27-12 |
| Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers | 01-27-12 |
| Verastem Bucks the Trend, Raises $55M in IPO | 01-27-12 |
| Shout Outs for Avila From Polaris, Atlas, & the Twittersphere | 01-26-12 |
| New England's Rising Biotech CEOs to Gather at April 4 Xconomy Event | 01-26-12 |
| Celgene Buys Avila for $350M, Gaining Promising ?Covalent? Drugs | 01-26-12 |
| San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More | 01-26-12 |
| Theraclone, VLST Founders Form New Antibody Startup, V-Gene | 01-26-12 |
| Biotech Is Raising More Cash, But Don?t Be Fooled: Startups are Hurting | 01-23-12 |
| Constant Contact, Bluefin Labs, HP, & More Boston Dealmakers | 01-25-12 |
| Roche Makes $5.7B Hostile Takeover Bid for Illumina | 01-25-12 |
| Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly | 01-25-12 |
| Family Affair: Courtagen Applies Management DNA to Genomics Startup | 01-25-12 |
| Affymax Prepares to Mount First Challenge to Amgen Anemia Drug Monopoly | 01-25-12 |
| Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race | 01-24-12 |
| Angry at the Genome | 01-25-12 |
| Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx | 01-23-12 |
| Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race | 01-24-12 |
| Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx | 01-23-12 |
| Novo Nordisk Adds Diabetes Research to Seattle Immunology Team | 01-23-12 |
| San Diego Tech Roundup: Venture Capital, Tealium, Qualcomm, & More | 01-23-12 |
| Biotech Is Raising More Cash, But Don?t Be Fooled: Startups are Hurting | 01-23-12 |
| Clarus Ventures Adjusts to Unpredictable Biotech World | 01-20-12 |
| Report: UCSF Chancellor Proposes Autonomy in State University System | 01-20-12 |
| Report: UCSF Chancellor Proposes Split from State University System | 01-20-12 |
| Infinity Offers Hint Of Effect With Pancreatic Cancer Drug | 01-20-12 |
| Millennium, Looking to Fend Off Onyx, Awaits FDA Word on New Velcade | 01-20-12 |
| Genzyme, Veracyte Strike Deal to Market Thyroid Cancer Diagnostic | 01-20-12 |
| In Life Sciences Partnerships, You Must be Smart from the Beginning | 01-20-12 |
| Millennium, Looking to Fend Off Onyx, Eagerly Awaits FDA Word on New Velcade | 01-20-12 |
| Clarus Ventures Looks to Steer Ship Through Less Predictable Biotech Seas | 01-20-12 |
| San Diego VC Activity at Ebb Tide in 2011 and Top 10 Local Deals | 01-20-12 |
| Xconomist of the Week Chris Rizik: Who Says A VC Has No Soul? | 01-19-12 |
| SD Life Sciences News: Auspex, BrainCells, and J&J's Startup Center | 01-19-12 |
| Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans | 01-19-12 |
| Xconomist of the Week Chris Rizik: Who Says A VC Has No Soul? | 01-19-12 |
| Xconomist of the Week Chris Rizik: Who Says VC Has No Soul? | 01-19-12 |
| Xconomist of the Week Chris Rizik: Who Says VC Has No Soul? | 01-19-12 |
| Reinventing Biotech's Business Model: Leaders Converge in Seattle April 3 | 01-19-12 |
| Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis | 01-19-12 |
| A Good News-Bad News Night for Bristol's Diabetes and Hepatitis Drugs | 01-19-12 |
| Reinventing Biotech's Business Model: National Leaders Coming to Seattle April 3 | 01-19-12 |
| Frazier Looks to Build Biotechs For Sale, Lay Groundwork for First Post-Crisis Fund | 01-19-12 |
| Cadence Biomedical Snags First $1M to Help Disabled People Walk | 01-18-12 |
| J&J Opens San Diego Biotech Startup Center, Says ?No Strings Attached? | 01-18-12 |
| Global Healthcare | 01-18-12 |
| RaNA Raises $20.7M From Atlas, SR One, Monsanto, for RNA-Based Tech | 01-18-12 |
| Biology 101 | 01-18-12 |
| From AI to Bioengineering | 01-18-12 |
| Onyx, Bayer's Next Cancer Drug Shows Slim Survival Edge | 01-18-12 |
| Xconomists Peer into the Future, Suggest How Students Should Prepare | 01-17-12 |
| Medivation Fails Alzheimer's Trial, Pfizer Drops Out of Partnership | 01-17-12 |
| Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks | 01-17-12 |
| Genentech Pours $95M Into Constellation's Drug Platform | 01-17-12 |
| Reinventing the Board Part III: The Agenda | 01-17-12 |
| Genentech Pours $95M Into Constellation's Epigenetic Drug Platform | 01-17-12 |
| Sanofi CEO Chris Viehbacher on Stirring Innovation in the Era of R&D Cutbacks | 01-17-12 |
| JP Morgan: Where the Boys Are?And Not the Girls | 01-16-12 |
| Axonia Medical Raises $1 Million in Seed Financing | 01-13-12 |
| Seattle Genetics Sees Updated Side Effect Warning in Drug Label | 01-13-12 |
| The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More | 01-13-12 |
| San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More | 01-12-12 |
| Q4 Venture Deals, Dollars Stayed Strong, Making 2011 Best in a Decade | 01-12-12 |
| Greenwashing | 01-12-12 |
| LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News | 01-11-12 |
| Amicus Counts on ?Chaperone? Tech to Enhance Rare Disease Treatments | 01-11-12 |
| Slain Biotech Investor Leaves $1 Million to Support Entrepreneurship | 01-11-12 |
| Flagship Closes New $270M Fund For Healthcare and Cleantech Ventures | 01-11-12 |
| Me-Too Drugs | 01-11-12 |
| Regulatory Overkill | 01-11-12 |
| LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News | 01-11-12 |
| Motorola Venture Arm Puts $6.5 Million Into MicroPower Technologies | 01-10-12 |
| The Situation at the FDA: We Are All to Blame | 01-10-12 |
| Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement | 01-10-12 |
| Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week | 01-10-12 |
| Warp Drive Bio Launches With $125M from Third Rock, Greylock, Sanofi | 01-10-12 |
| Foundation Medicine And Sanofi Form Cancer Discovery Pact | 01-10-12 |
| Of Patent Rats and Blaming Teachers | 01-10-12 |
| Canaan Partners Survives VC Turmoil, Raises New $600M Tech/Biotech Fund | 01-09-12 |
| Lack of Funding For Innovative Biotech Companies | 01-09-12 |
| Bayer, Keeping Tabs on the ?Hood, to Open Labs For Mission Bay Startups | 01-09-12 |
| Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes | 01-09-12 |
| Five Myths You?ll Hear This Week at the JP Morgan Healthcare Conference | 01-09-12 |
| Astellas Scraps Antibiotic Partnership With Theravance | 01-06-12 |
| PacBio CEO Hugh Martin Resigns, Being Replaced by Mike Hunkapiller | 01-06-12 |
| Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers | 01-06-12 |
| Langer, Farokhzad Start New Combo Drug Company, Blend Therapeutics | 01-06-12 |
| Civitas Charts Positive Data on Inhaled Parkinson's Drug | 01-06-12 |
| Gene Security Network, Now Natera, Adds $20M For Prenatal Tests | 01-06-12 |
| San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More | 01-06-12 |
| Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers | 01-06-12 |
| Mirador Biomedical Gets FDA Green Light to Expand Use of Digital Sensor | 01-06-12 |
| Survey: Tech Executives Saw More Pay in 2011, Life Sciences Inched Up | 01-05-12 |
| Survey: Tech Executives Saw More Pay in 2011, Life Sciences Inched Up | 01-05-12 |
| Survey: Tech Executives Saw More Pay in 2011, Life Sciences Inched Up | 01-05-12 |
| Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms | 01-05-12 |
| Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs | 01-05-12 |
| Inspiration Bio Founders and Execs Inspired by New Boston Headquarters | 01-04-12 |
| Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment | 01-04-12 |
| Novo Leads New $30M Round for San Diego's Elevation Pharmaceuticals | 01-04-12 |
| Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug | 01-04-12 |
| Allozyne ?Redistributes? Workforce After Scrapping Poniard Merger Plan | 01-04-12 |
| JeNu Biosciences Raises $1.5M for Ultrasound to ?Put Good Things in Skin? | 01-03-12 |
| SD BizTech Roundup: Qualcomm, Razer, Avalon's Zynga Windfall, & More | 01-03-12 |
| Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls | 01-03-12 |
| Diabetes Drugs Could Cure Cancer | 01-03-12 |
| Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls | 01-03-12 |
| VelQuest Bought by Accelrys for $35M | 01-03-12 |
| Healthcare That Works | 01-03-12 |
| All-Electric Transportation | 12-30-11 |
| Technology That Finally Helps Learning | 12-30-11 |
| The Big Stories of 2011 at Xconomy San Francisco | 12-29-11 |
| Detroit in 2012: The Rebirth Story That's For Real | 12-29-11 |
| Healthy Transgenic Foods | 12-28-11 |
| The Top 10 Traffic-Getting Stories at Xconomy San Diego | 12-28-11 |
| Xconomy Seattle's Top 12 Life Sciences Stories of the Year | 12-28-11 |
| Editor's Picks: Xconomy Boston's Top 20ish Stories of 2011 | 12-28-11 |
| Cure for Diabetes | 12-28-11 |
| Bacteria to Do Our Bidding | 12-27-11 |
| Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 | 12-27-11 |
| Beyond the iPad to the hPad | 12-27-11 |
| Acceleron Adds $30M From Partner Celgene and Existing Investors | 12-23-11 |
| WGBH Xconomy Report: TripAdvisor, Amazon, & More | 12-23-11 |
| Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles | 12-23-11 |
| Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines | 12-23-11 |
| Momenta, Baxter Team up on Biosimilars | 12-23-11 |
| WGBH Xconomy Report: TripAdvisor, Amazon, & More | 12-23-11 |
| Boston's Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers | 12-23-11 |
| A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine | 12-23-11 |
| Acceleron Adds $30M From Partner Celgene and Existing Investors | 12-23-11 |
| The Year in Seattle Medical Devices, Diagnostics, Health IT | 12-23-11 |
| Enabling the Cleantech Revolution | 12-23-11 |
| Avalon's Kinsella Toasts Debut Vintage of Another Venture | 12-23-11 |
| 24-Hour, Full-Genome Scans | 12-23-11 |
| Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines | 12-23-11 |
| Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy | 12-22-11 |
| Potential Treatment for Degenerative Eye Diseases Developed at Wayne State | 12-22-11 |
| San Diego Life Sciences Roundup: Intellikine, Somaxon, and More | 12-22-11 |
| Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy | 12-22-11 |
| Early Pharma Partnership Proves Key to Armgo's Startup Success | 12-22-11 |
